Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01JGB
|
||||
| Former ID |
DNC010610
|
||||
| Drug Name |
4-cyclooctyl-6-propylpyrimidine-2-carbonitrile
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530717] | ||
| Formula |
C16H23N3
|
||||
| Canonical SMILES |
CCCC1=NC(=NC(=C1)C2CCCCCCC2)C#N
|
||||
| InChI |
1S/C16H23N3/c1-2-8-14-11-15(19-16(12-17)18-14)13-9-6-4-3-5-7-10-13/h11,13H,2-10H2,1H3
|
||||
| InChIKey |
AWOXPJKLDJGFMS-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | Inhibitor | [530717] | |
| Cathepsin S | Target Info | Inhibitor | [530717] | ||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.